Form 4: Labcorp EVP Sandra van der Vaart Reports Stock Sale
SEC Form 4 Filing
Sandra van der Vaart, EVP and Chief Legal Officer of Labcorp, reported selling 1,900 shares of common stock on May 1, 2025.
Summary
- Sandra D. van der Vaart, EVP and Chief Legal Officer of Labcorp Holdings Inc., filed a Form 4.
- On May 1, 2025, van der Vaart sold 1,900 shares of Labcorp common stock at a price of $238.36 per share.
- Following the transaction, van der Vaart directly owns 2,243.5397 shares of Labcorp common stock.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a stock sale by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The sale of shares by an executive could be perceived negatively by some shareholders, but it is a common occurrence and doesn't necessarily indicate a negative outlook for the company.
Key Dates
| Date | Description |
|---|---|
| 05/01/2025 | Date of transaction: Sale of 1,900 shares of common stock. |
| 05/05/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, insider trading, stock sale, Labcorp, van der Vaart, LH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.